* Treace Medical Concepts Inc TMCI.OQ reported a quarterly
adjusted loss of 20 cents per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 24 cents per share.
* Revenue rose 40% to $41.95 million from a year ago;
analysts
expected $40.85 million.
* Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 20 cents.
* The mean earnings estimate of analysts had fallen by
about 7.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Treace Medical Concepts Inc shares had fallen by 18.9%
this
quarter and lost 9.8% so far this year.
* The company reported a quarterly loss of $12.27 million.
* Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $30.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 9 at 03:33 a.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.24 -0.20 Beat
Mar. 31 2023 -0.23 -0.23 Met
Dec. 31 2022 -0.14 -0.08 Beat
Sep. 30 2022 -0.29 -0.22 Beat